SunTrust Robinson Humphrey Upgrades Tetraphase Pharmaceuticals (TTPH) to Buy
Tweet
Share
E-mailGet Alerts TTPH Hot Sheet
Price: $2.20 --0%
Rating Summary:
6 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
6 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
SunTrust Robinson Humphrey upgraded Tetraphase Pharmaceuticals (NASDAQ: TTPH) from Neutral to Buy with a price target of $21.00.
For an analyst ratings summary and ratings history on Tetraphase Pharmaceuticals click here. For more ratings news on Tetraphase Pharmaceuticals click here.
Shares of Tetraphase Pharmaceuticals closed at $10.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- TD Cowen Upgrades Bank of Nova Scotia (BNS:CN) (BNS) to Buy
- UBS Upgrades Fluence Energy Inc. (FLNC) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
